Showing 35,658 results

How HIV works

HIV replication can continue in the intestines even with successful antiretroviral therapy

News
25 September 2007
Transmission & prevention

PrEP could prevent up to three million HIV infections in ten years in Africa

News
25 September 2007
Hepatitis & HIV

Sexual transmission of hepatitis C in HIV-positive gay men reported in Australia

News
24 September 2007
Side effects

Urinary stones a rare side-effect of atazanavir

News
24 September 2007
The search for an HIV prevention vaccine

Merck HIV vaccine fails, trials halted

News
22 September 2007
Resistance

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

News
21 September 2007
New & experimental HIV treatments

ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody

News
21 September 2007

ICAAC: Serious but non-AIDS-defining illnesses more frequent at lower CD4 counts and higher viral loads

News
21 September 2007
New & experimental HIV treatments

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir

News
21 September 2007
Side effects

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

News
21 September 2007
Transmission & prevention

Return of nelfinavir's European license recommended

News
21 September 2007
New & experimental HIV treatments

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV

News
20 September 2007
New & experimental HIV treatments

ICAAC: Dapivirine safe and tolerable as potential vaginal microbicide; displays potential in combination with other agents

News
20 September 2007
Cancer

ICAAC: Incidence of non-AIDS-defining cancers remains higher for HIV-positive individuals despite HAART

News
20 September 2007
People with limited treatment options

ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced

News
20 September 2007
Epidemiology

ICAAC: Sharp decline in HIV prevalence reported in pregnant women in rural northern Zimbabwe

News
20 September 2007
Sexually transmitted infections prevention

ICAAC: Gardasil provides some protection against wide spectrum of cancer-causing HPV

News
19 September 2007
How HIV works

ICAAC: Dual/mixed tropic virus speeds disease progression as much as tenfold increase in viral load

News
19 September 2007
People with limited treatment options

ICAAC: Vicriviroc safe, effective after 2 years, phase III studies start soon

News
19 September 2007
Treatment interruptions

ICAAC: In NNRTI-based regimens, stepwise discontinuation minimises risk of antiretroviral resistance

News
19 September 2007
People with limited treatment options

ICAAC: Raltegravir shows sustained effect in highly treatment-experienced patients

News
19 September 2007
Starting treatment

ICAAC: Boosted darunavir non-inferior to boosted lopinavir after 48 weeks in treatment-naïve

News
19 September 2007
People with limited treatment options

ICAAC: Best response to elvitegravir seen when used with T-20 and other active agents

News
19 September 2007

HIV Weekly - September 19th 2007

September 2007